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Open access under A B S T R A C TAvailable online 5 March 2013 The establishment of extremely powerful proteomics platforms able to map thousands of
modification sites, e.g. phosphorylations or acetylations, over entire proteomes calls for
equally powerful software tools to effectively extract useful and reliable information from
such complex datasets. We present a new quantitative PTM analysis platform aimed at
processing iTRAQ or Tandem Mass Tags (TMT) labeled peptides. It covers a broad range of
needs associated with proper PTM ratio analysis such as PTM localization validation, robust
ratio computation and statistical assessment, and navigable user report generation. IsobarPTM
is made available as an R Bioconductor package and it can be run from the command line by
non R specialists.
Biological significance
“IsobarPTM is a new software tool facilitating the quantitative analysis of protein
modification regulation streamlining important issues related to PTM localization and
statistical modeling. Users are provided with a navigable spreadsheet report, which also
annotate already public modification sites.”
This article is part of a Special Issue entitled: From Genome to Proteome: Open Innovations.
© 2013 Elsevier B.V. Open access under CC BY-NC-ND license.Keywords:
Bioinformatics
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Statistics1. Introduction
The dynamic execution of the genetic program encoded in the
genome is controlled by a multitude of regulatory mechanisms
such as transcription factors, alternative splicing, silencing by
non coding RNAs, and epigenetic marks. The large repertoire of
gene products generated by the translation/transcription ma-
chinery is further submitted to another level of modulation
provided by PTMs. Thesemodifications increase the diversity of
biomolecules available to cells to adapt to environmental
changes or to assemble in specialized tissues.
A large number of PTMs have been described (591 entries in
the RESID [1] database vers. 70.01) which modify the properties
of proteins for diverse purposes and whose deregulated control
can cause multiple disorders. A classical and very importantled: From Genome to Prot
0; fax: +43 140160970000.
at (J. Colinge).
CC BY-NC-ND license.example is the phosphorylation of threonine, tyrosine, or serine
that is used to activate proteins upon specific stimuli and to
realize signaling cascades [2]. Dysfunctions in such signaling
can cause cell proliferation and cancer. More generally, PTMs
participate in signal integration within the cell, protein degra-
dation, binding, etc. Commonly studied PTMs are catalyzed by
enzymes such as kinases, phosphatases, or acetyltransferases.
It has been also shown that distinct PTMs can have a cross-talk,
e.g. to establish substitution strategies when one is deficient [3].
Given the importance of PTM regulation in a broad range of
biological processes, the analysis of their differences across
biological samples is of prime interest in proteomics and is best
achieved with quantitative techniques. The measure of PTMs
byMS is generally challenging [4,5] sincemostmodifications are
lost upon ionization or fractionation resulting in lowMS signalseome: Open Innovations.
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equipments in particular conditions. A number of analytical
protocols – often relying on chromatographic enrichment for
the PTM of interest – have been established successfully, e.g. in
the case of phosphorylation [6], ubiquitinylation [7], or acetyla-
tion [8].
In this work, we present isobarPTM a new software tool
aimed at analyzing the MS/MS spectra of modified peptides
resulting from isobarically labeled samples using the Tandem
Mass Tags [9] (TMT) or iTRAQ [10] reagents. IsobarPTM is a
peptide level extension of the isobar statistical and software
framework which we introduced for the analysis of protein
ratios [11]. The analysis of modified peptides does not only
require determining peptide ratios instead of protein ratios
but actually necessitates additional data processing steps.
These include the validation of the modification sites on the
peptides, the integration of publicly known PTMs, and the
relation of modified peptide ratios with the corresponding
protein ratios to eliminate apparent PTM regulation caused
by the sole protein regulation. As it was the case previously,
this new PTM extension is released as free open source software
implemented inRandavailable aspart of the isobarBioconductor
package. It provides a complete workflow for handling quantita-
tive PTM data from their validation to user report generation.
Currently, Mascot [12], Phenyx [13], Rockerbox [14], comma
separated, and PSI mzIdentML identification formats are
supported. Isobar is available from the Bioconductor web site
(http://www.bioconductor.org).2. Materials and methods
Programming was done in the R statistical programming
language [15] and all the features described in this paper
were implemented in the isobar package [11]. The novel PTM
functionality is accessible via user report generation options
and new specific functions of isobar.
The access to public PTMs from neXtProt [16] is performed
via REST-compatible searches (URL http://www.nextprot.org/
rest/). The results are retrieved in JSON format and parsed into
the ptm.info data frame of the isobar package.
Integration of the PhosphoRS [17] phosphorylation localiza-
tion tool was realized by using the free stand-alone command
line version of PhosphoRS. PhosphoRS does not feature a
graphical user interface but requires XML input instead.
IsobarPTM integrates generic readers and writers for such a
situation and thus provides a seamless interface to PhoshpoRS
and other similar external tools.
Validation of statistical models at the peptide level was
achieved using data from isobar original publication [11] to
assess true and false positive rates of peptide selection as well
as the adequacy of the statistical distributions underlying isobar
statistics. We further validated the ratio null distribution
2.1. Application sample data
We downloaded Phanstiel et al. raw MS data [18] from Tranche.
Peak picking and processing was performed using ProteoWizard
[19] and the resulting peak lists were searched with Mascot 2.3.0
against the UniProtKB/SwissProt human database [20] appendedwith sequences of common contaminants (sheep keratin and
bovine serumalbumin). Fixedmodificationswere set to cysteine
Carbamidomethylation, iTRAQ 4-plex at the peptide N-terminus
and lysine side chains. Methionine oxidation was set as variable
modification. The phosphodatasetwas searchedwith phosphor-
ylation on serine, threonine, and tyrosine residues as variable
modifications and mass tolerance was set according to the
original publication [18], i.e. precursors 4.5 Da and fragments
0.01 Da. In-house developed scripts were used to filter peptide-
spectrummatches to a 1% falsediscovery rate (FDR) at theprotein
group and peptide level utilizing reversed database searches.
Accordingly, proteins with 2 unique peptides above an ion score
threshold of 16, or with a single peptide above a threshold of 40
were selected as unambiguous identifications. Additional pep-
tides for these validated proteins with ion score >12 were also
accepted. Only those peptides with a PhopshoRS [17] probability
>0.9 were considered for quantitation. The quantification was
performed with default isobar settings. From the peak lists,
fragments with reporter tag mass +/− 0.005 m/z were extracted
and corrected for isotopic impurities. iTRAQ channels were
normalized to an equal median intensity. The higher-energy
c-trap dissociation (HCD) noise model supplied with the isobar
package was used.3. Results and discussion
In our previous work [11] that established the isobar statistical
framework we carefully integrated important elements for
selecting significant ratios. Briefly, we eliminated outlier ratios
from individual spectra obviously distorted by co-eluting pep-
tides and modeled the technical as well as the biological
variability. This allowed for a simple and safe selection of protein
ratios thatwere reliablymeasured andwith sufficientmagnitude
compared to the sample natural variability. This previous work
also included generalized statistical models to take advantage of
replicates with a single iTRAQ or TMT experiment, and, in
general, put great emphasis on the value of statistically
sound methods to obtain robust and competitive methods.
Here, we describe isobarPTM, the extension of isobar for the
analysis of modified peptide ratios.
Clearly, to bring the whole analysis to the peptide level
requires computing peptide ratios instead of protein ratios.
That is, all the spectra assigned to a specific peptide/PTM
combination (distinct copies of the same peptide can display
different patterns of PTMs) are combined in a single weighted
ratio calculation taking into account signal intensities and
technical variability as previously described for the protein level
[11]. Beyond the change in the analysis level, several additional
issues that are specifically related to PTManalysis arise andmust
be properly addressed (Fig. 1). In this section, we present and
discuss these various issues followed by two general improve-
ments relevant to PTMquantitation and a comparisonwith other
tools.
3.1. Validation of PTM site localization
The localization of PTM sites onmodified peptides identified by
MS can be ambiguous and, accordingly, only reliably localized
PTMs should enter the quantitative analysis. This problem
isobarPTM quantification pipeline
Site Localization
Delta Score
PhosphoRS
Peptide Ratio Calculation &
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Proteome
Changes
Analysis Report Generation
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PhosphoSitePlus
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Fig. 1 – Workflow for generating quantitative PTM analysis reports. Peptide–spectrummatches with uncertain localizations of
the modifications are removed using a difference or probability score (red box). Reliable matches are used to calculate ratios of
modified peptides. Protein ratios froma separate experiment (blue box) can beused to correctmodified peptide ratios (solid line) or
integrated in the analysis report, and aredisplayednext to themodifiedpeptide ratios (dotted line). Theanalysis report (greenbox)
in Excel format integrates previously published knowledge on identified sites, harvesting neXtProt and PhosphoSitePlus. A PDF
report containing quality control figures is generated.
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certain PTM. For instance the peptide AAGSWHSILSK can be
phosphorylated at 3 positions (serines) and if it is singly
phosphorylated there are 3 possible localizations. Protein identi-
fication search engines provide scores for peptide–spectrum
matches that can identify the correct localization provided the
peptide fragment coverage is sufficient. In practice, nonethe-
less, the score alone is not reliable enough [21]. To generally
address this issuewe integrated auniversalmethodof validating
PTM localizations, i.e. the Mascot Delta Score [22]. Although this
technique was introduced for phosphorylations and is based on
Mascot peptide ion scores, it is in reality of general applicability.
It compares the difference between the best- and second best-
scoring peptide–spectrummatches for a given peptide and PTM,
with distinctmodification sites, e.g. AAGS(phos)WHSILSK versus
AAGSWHS(phos)ILSK to refer to the above example. The peptide
identification score difference informs on the amount of infor-
mation in the fragmentation spectrum to support one localiza-
tion versus another one. It provides a measure of confidence in
the localization and its analysis was performed by its authors.
Since it only relies on score differences it is applicable to any PTM
under the condition that the search engine provides multiple
peptide/PTM matches for each spectrum and not only the
best-scoring one. This is the case of Mascot and many other
programs such as Phenyx.Given the importance of identifying phosphorylated pep-
tides, more advanced procedures of reliable localization have
been proposed for this specific case [17,23–27]. To offer the
possibility to implement or use external specialized and different
PTM localization functions we introduced a generic mechanism
of spectrum annotation in isobarPTM, which we exploited to
integrate PhosphoRS [17] for phosphorylation localization as an
alternative to the Mascot Delta Score approach.
3.2. Summarizing and quantifying at the level of themodified
peptides
As explained above the computation of modified peptide ratios
necessitates introducing another level of organization in the
data such that all the spectra –with safe PTM localizations – can
be combined for one specific peptide sequence and PTMpattern.
We validated that the statistical models introduced for the
protein level [11] are still valid at the peptide level by repeating
the analysis we conducted for protein ratios [11]. In particular,
we assessed that (1) a heavy tailed distribution is appropriate to
model peptide ratio null distributions (Supplementary Figs.
S1–S3); (2) regulated peptide selection false positive rates are
accurately estimated by the statistical models (Supplemen-
tary Table S1). We further estimated the true positive rate for
different peptide ratios and underlying protein abundance
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ratio results strongly, are not surprising since isobar protein and
peptide ratios are computed identically. As a matter of fact, we
donot distinguish between different peptideswhenwe compute
protein ratios [11]meaning that a ratio is always aweighted sum
in our calculations (sum because we work in the log-scale and
weighted by a variance estimate of each spectrum ratio [11]).We
concluded this validation by showing that modified peptide
ratios also follow a heavy tailed distribution (Supplementary
Fig. S4).
The accurate modeling of modified peptide ratios is not
necessarily sufficient to obtain biologically relevant results.
The observed ratio of a modified peptide is the integrated
change of the modification state and the underlying protein
abundances and, when quantifying modification state changes,
the change in protein abundance – if measured – should not be
ignored. Wu et al., comparing the phosphoproteomes of FUS3 or
STE7 yeast knockout strains againstwild type [28], discussed this
problem in great detail and found that 25% of the apparently
regulated phosphopeptides disappeared after protein ratio
correction. Having access to a high coverage of the proteome in
yeast, theywere able to calibrate over 96%of thephosphopeptide
ratios. In our experience, working with human samples, the
overlap between the proteins detected with both unmodified
peptides, to estimate protein abundance change, and modified
peptides simultaneously resides in the 60–90% range depending
on the sample. Note that a PTMenrichment procedure preceding
MS, as it is commonly done for phosphopeptidemapping, might
require measuring the protein ratios from a separate set of
samples. In isobarPTM, we enabled the optional correction of
modified peptide ratios when the protein ratio is available, in
which case the peptide ratio is divided by the protein ratio.
Namely, if Rn is the observed modified peptide ratio and Rp the
observed protein ratio, then Rm, the corrected peptide ratio
(i.e. its modification state change), is Rm = Rn − Rp (ratios in
the log-scale). An adjustment to the estimated variance of
Rm is also determined to comply with our general procedure
of selecting significantly regulated peptides; the formulas
are provided as Supplementary Information.
To exemplify ratio corrections on a human sample, we
decided to reanalyze the iTRAQ 4-plex dataset published by
Phanstiel et al. [18], who compared embryonic stem cell (ESC)
lines with induced pluripotent stem cell (iPSC) lines and a
fibroblast cell line. Using the ESC H1 as a reference, in line with
the authors, we found that the strongest difference in phosphor-
ylation is observed when comparing with the fibroblast cell line
NFF (Fig. 2A),whereas thedifferences comparingH1withanother
ESC line H9 and an iPSC line DF19.7 were very modest (ESCs are
similar to iPSC [18]). Turning to the question of correcting
phosphorylation site ratios with protein ratios, we found protein
ratios for 77%of the phosphopeptideswe identified. Applying the
same fold-change threshold of 2 as Phanstiel et al., 48% of
corrected phosphopeptide ratios were no longer significant after
correctionwith amatching protein ratio, amassive change in the
overall sample picture (Fig. 2B & C). Specific examples of four
phosphorylated peptides are shown in Supplementary Fig. S5,
including cases where the corrected ratio is augmented,
reduced, and reversed compared to the original ratio.
Analyzing the enrichment of specific GO terms in differ-
entially expressed and phosphorylated proteins using DAVID(http://david.abcc.ncifcrf.gov), we could recapitulate the find-
ings of Phanstiel et al. Proteins higher in ESCs compared to NFF
were enriched in cell cycle-related processes (e. g. chromosomal
organization), those higher inNFFwere enriched in cytoskeletal
processes.
3.3. Generation of user reports and integrationwith published
PTM data
The isobar package creates reports for quality control (Fig. 3)
and quantification analysis and this feature has been extend-
ed to cover modified peptides. Reporting results at the peptide
level dramatically augments the size of the data to return to
the user and the PDF report we generate for the protein level is
no longer appropriate. We hence extended and made fully
navigable the already existing spreadsheet user report to also
accommodate the peptide level (Fig. 3). It now provides links
from quantified peptides to identified spectrum matches,
enabling checking of the raw data, etc. Identification informa-
tion includes search engine scores, modification site local-
ization scores, and extracted isobaric report masses and
intensities.
Public databases collect thousands of protein modification
sites reported in the literature. To present an overview of
existing knowledge about experimentally identified modifica-
tion sites, we query PTM information-containing databases
during user report generation. The neXtProt database [16] is our
main source, which we reach via their on-line API (Materials
and methods). An alternative source we also support is
PhosphoSitePlus [29] that provides a second comprehensive
resource of experimentally observed PTMs, primarily phos-
phorylations although ubiquitinylations and acetylations are
covered as well. Isobar integrates PhosphoSitePlus data, auto-
matically downloading the most recent of their monthly
updated datasets at the time of report generation, parsing
and mapping the data to the experimentally identified
proteins. The isobarPTM PTM annotation framework allows
users to include supplementary PTM annotation resources if
needed.
3.4. Further improvements
Having described all the necessary new functionalities
implemented to support the analysis of quantitative PTM
data, we briefly mention two improvements of isobar that
are of general interest and thus impact modified peptide
data processing as well.
Firstly, combinations of CID with HCD or electron transfer
dissociation (ETD) fragmentation methods are commonly used
in iTRAQ or TMT protocols to achieve more identifications on
the basis of a fast method (CID), while more accurate quanti-
fication is obtained on the basis of the slower but more precise
method (HCD or ETD) limited to a narrow mass range covering
the iTRAQor TMT channels [30]. In such a case, isobar canmerge
identification runs (e.g. from CID) and quantification runs
(e.g. from HCD spectra) while reading the MS data, and even
combine identifications obtained from quantification runs
when they include regular fragment information as well. For
instance, CID and HCD can provide complementary peptide
identifications [31], which in our laboratory equipped with an
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Fig. 2 – Analysis of Phanstiel et al. data. Ratios are relative to the 114 channel corresponding to H1 embryonic stem cells. (A) We
observe the larger spread of ratios both in the phosphoproteome (top) and the proteome (bottom) when comparing to NFF
fibroblast cells (red, channel 115) compared to H9 embryonic stem cells (green, channel 116) and DF19.7 induced pluripotent
stem cells (blue, channel 117). (B) Protein ratios versus phosphopeptide ratios.We note the positive correlation indicating that a
significant part of the phosphopeptide ratios originate from the protein regulation and not the phosphorylation site regulation.
(C) Original versus corrected phosphopeptide ratios. The slope 0.63 < 1 confirms the general reduction of the ratios after
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81J O U R N A L O F P R O T E O M I C S 9 0 ( 2 0 1 3 ) 7 7 – 8 4LTQ-Orbitrap Velos (ThermoFisher Scientific, Waltham, MA)
each account for 20–30% of the peptide–spectrummatches in
the analysis of phosphopeptide enriched fractions.
Secondly,we could findamoreaccuratemodel of heavy tailed
distribution than the Cauchy.Wehave observed that generalized
Student's t distribution better models the tails and thus improve
the sensitivity of isobar (Supplementary Figs. S1–S4, S6). This
distribution belongs to the generalized logistic distribution
family that is a very general model of heavy tailed distribu-
tion parameterized by five parameters, which is toomuch for
practical applications where data can be sparse. The general-
ized Student's t distribution has three parameters as compared
to Cauchywhich has only two, and it is a widely usedmodel for
heavy tailed distributions. Cauchy remains isobar default to
ensure maximum robustness with smaller datasets (less than
1000 ratios, Supplementary Table 3).
3.5. Use without programming
The presented tool can be used with minimal configuration
and no direct interaction with R: a plain text property file
specifies basic parameters such as the isobaric tagging kit
used (iTRAQ/TMT, 2-, 4-, 6-, or 8-plex), peak list and identification
file names, and how the report and quantification should beproduced (see Fig. 3). An R script, which can be called from the
command line, runs the analysis with the provided parameters
and generates the results. Many further options can be specified
to customize the analysis and report — examples are provided
with the package to guide beginners.
3.6. Comparison with existing tools
In Table 1 we present a feature comparison of software used
in recent publications for the quantitation of isobarically tagged
PTMexperiments. The Coon group has developed theCOMPASS
[32] proteomics analysis suite for OMSSA, used recently for the
quantitation of stem cell proteomes and phosphoproteomes
[18]. The Marto group introduced Multiplierz [33] that provides
an excellent basis for extensible workflows and data access and
has been used for example for the quantitation of the mTOR
regulated phosphoproteome [34]. Thermo Scientific's commer-
cial Proteome Discoverer enables to construct a workflow from
identification to quantitation. As it can be appreciated from the
table, isobar's distinguishing features are its statistical funda-
ment for quantitation and significance analysis, the high level
integration of public PTM data for report generation, and the
configurability and extensibility with bioinformatics packages
for R/Bioconductor.
A) Quality Control Report B) Report Properties
C) Analysis Report
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Fig. 3 – IsobarPTM quantification reports. (A) Quality control report showing reporter tag mass precision, reporter tag intensities before and after normalization, and a histogram
of peptide ratios along with the fit Cauchy biological variability ratio distribution [11]. (B) Report generation is controlled by a properties file. Columns: property name, possible
values, and explanation. (C) Spreadsheet user report. It includes modified peptide sequence with the positions of the modifications in the protein sequence (separated by
semicolons if in multiple identical peptides or by ampersands if multiple occurrences in the same peptide). A star identifies positions previously reported in the literature,
tooltips display information on the latter PTMs (here from neXtProt). The report has multiple tabs for identifications and contains multiple links to navigate them, e.g. from a
modified peptide as featured in the figure to all the spectra supporting its identification.
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Table 1 – Comparison with similar software packages.
IsobarPTM Proteome
Discoverer
COMPASS multiplierz
Availability Open source Commercial Open source Open source
iTRAQ and TMT Quant Yes Yes Yes Yes
Statistical Framework Yes, technical and biological
variability
no no Technical variability modeleda
PTM Localization Yesb Yes c No Yes a
Annotation of PTM sites Yesd No No No
Correction with Protein Ratios Yes Yes Yes Yes
Restrictions No graphical user interface Closed
source
For usage with OMSSA
only
Scripting skills required
a Scripts for robust error model and Mascot Delta Score available on the multiplierz homepage http://blais.dfci.harvard.edu/index.php?id=106.
b PhosphoRS and Mascot Delta Score.
c PhosphoRS.
d NextProt and PhosphoSitePlus.
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To measure and understand PTMs in disease and biological
processes is an important objective of current research in
proteomics. Such experiments remain challenging but the
technology has made such tremendous progresses that
in-depth and proteome-scale mappings of specific PTMs
can be realized with unprecedented accuracy. As a conse-
quence, data analysis faces difficulties that are common to
most omics fields: the access to reliable and highly automated
methods of processing and selecting relevant data conditions
the extent to which discoveries can be accomplished.With this
consideration in mind, we started to develop a combined
statistical and software framework – isobar – that we originally
targeted towards protein expression studies [11]. The work
presented here implements a second step aimed at including
the peptide PTM regulation level within the scope of the
analyses supported by this platform. We named this specific
branch of the project isobarPTM.
The approach we have followed remains in line with the
original concepts that guided isobar design: the establishment
of robust and accurate statistical models provides the most
appropriate basal layer to construct a successful software
platform. In isobarPTM we greatly benefited from the initial
effort to the point where no real additional statistical modeling
was necessary, just validations and small adaptations. The
models developed for the proteins turned out to be adequate for
the peptides as well and we could concentrate on establishing
the new software functionalities. Doing so, we also benefited
from the general improvements and bug-fixes we kept intro-
ducing in the isobar libraries that has beenapplied to amultitude
of projects by ourselves [35] and others [36] meanwhile.
Practically, successful and high quality analysis of PTM data
on a large-scale preventing the manual inspection of each and
every interesting spectrum implies the execution of several
tasks that are generally not all accessible to the average
proteomics laboratory in the best conditions. With isobarPTM
we have streamlined the fundamental steps of extracting
and combining identification and MS data, including when
hybrid fragmentation strategies e.g. CID-HCD are adopted,performing an automatic validation of the localization of the
modification sites and removing dubious cases, and applying
state of the art statistical modeling to compute ratios and
assess their significance (Fig. 1). Furthermore, convenient
user reports are produced which include a navigable sophis-
ticated spreadsheet that represents a convenient paradigm
for reporting large sets of results as generated by peptide
level studies.
Finally, we believe that bioinformatics tools should be as
interoperable as possible and the development of open
source R Bioconductor packages represents an effective way
of implementing this goal. In particular, follow up func-
tional analyses such as GO term or pathway enrichments
aremade straightforward thanks tomany existing Bioconductor
packages. Developing within the R platform allows other
bioinformaticians to use isobar at all possible levels, from
calling high-level functions down to completely redesigned
analyses capitalizing on the low-level functions. For non-
bioinformaticians and for usage within an automated pipeline,
we make the complete analysis with report generation acces-
sible on the command line requiring simple configuration via
text files only. In the future of the isobar project, we will give
significant attention to the development of a graphical user
interface.
Isobar and isobarPTM can be downloaded from http://www.
ms-isobar.org or from the Bioconductor web site.Acknowledgments
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